Osaka, Japan

Kiyomi Ohba

USPTO Granted Patents = 4 


Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kiyomi Ohba

Introduction

Kiyomi Ohba is an accomplished inventor based in Osaka, Japan. With a total of four patents to her name, she has significantly contributed to the field of pharmaceuticals, specifically in cancer treatment. Her innovative research has led to the development of new compounds that hold promise in improving therapeutic outcomes for patients.

Latest Patents

Ohba's latest patents include a focus on sulfonamide and sulfinamide compounds. These compounds are designed to induce the degradation of the BRD4 protein, which plays a critical role in cancer progression. The compounds she has developed show superior efficacy in this action, making them valuable as therapeutic agents. Each patent is represented by specific formulas and is described in detail, emphasizing their potential for pharmaceutical applications.

Career Highlights

Her career with Mitsubishi Tanabe Pharma Corporation has been noteworthy, allowing her to apply her research in a practical setting. Ohba's work is not only innovative but also pivotal in addressing pressing medical challenges, particularly in oncology.

Collaborations

Throughout her career, Kiyomi has collaborated with esteemed colleagues, including Ryuta Yamazaki and Tatsuya Ibuki. These partnerships have fostered an environment of creativity and shared expertise, further enhancing the effectiveness of her research initiatives.

Conclusion

Kiyomi Ohba's contributions to pharmaceutical innovations are invaluable. With her latest patents aimed at improving cancer treatment, she exemplifies the spirit of invention and dedication to advancing medical science. Her ongoing work at Mitsubishi Tanabe Pharma Corporation continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…